Work

Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer

Year: 2003

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-003-0573-4

Authors: Randall P. Rago, Albert Einstein, Richard Lush, Tomasz M. Beer, Yoo-Joung Ko, W. David Henner, Glenn Bubley, Elizabeth A. Merica, Varun Garg, Ene Ette, Matthew W. Harding, William S. Dalton

Institutions: Moffitt Cancer Center, Oregon Health & Science University, Beth Israel Deaconess Medical Center, Vertex Pharmaceuticals (United States)

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1591579405

FWCI: 1.052

Cites: 45

Cited by: 32

Related to: 10